The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

ELECTROSHOCK THERAPY

A Review of Over 23,000 Treatments Using Unidirectional Currents
Published Online:https://doi.org/10.1176/ajp.104.2.100

1. Forty percent of the most chronic patients showed significant improvement in ward behavior if adequately and repeatedly treated with suitable type of electroshock therapy. Relapses must be treated whenever they occur over months and years.

2. At least 60% of early cases, aged 60 or under, were rehabilitated within 1 year when adequately treated and 65% by the end of the second year after the start of treatment.

3. Adequate treatment means intensive treatment until the expected improvement has occurred and intensive treatment of relapses when they occur. No patient, otherwise suitable who still is not rehabilitated after 1 year, has had an adequate trial of treatment with less than 20 treatments.

4. An ideal therapy is one which achieves beneficial results without causing accumulating brain damage, thus permitting its use repeatedly for years if necessary.

5. This ideal is approached by the relatively low intensity 60-cycle pulsating direct current used in the treatment of the patients reviewed in this paper. This technique also has been accompanied by an exceptionally low percentage of skeletal complications.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.